Literature DB >> 1533903

SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons.

D Duval1, N Roome, C Gauffeny, J P Nowicki, B Scatton.   

Abstract

In the present study, we have examined by light and electron microscopy whether SL 82.0715, a polyamine site-directed N-methyl-D-aspartate (NMDA) antagonist, causes pathological changes in cerebrocortical neurons similar to those observed with NMDA receptor channel blockers in the rat brain. Dizocilpine (1, 2 and 5 mg.kg-1, s.c.) induced a dose-dependent vacuolization of the neuronal cytoplasm in specific neurons of the retrosplenial and posterior cingulate cortices (layers III and IV) even at the lowest dose studied, at 6 h post-injection. In contrast, SL 82.0715 (10 and 30 mg.kg-1 i.p., 6 h post-injection) did not induce such morphological alterations. These results indicate that NMDA receptor blockade is not necessarily associated with alterations of cortical neuronal morphology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533903     DOI: 10.1016/0304-3940(92)90402-s

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

2.  Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill; L L Iversen
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

3.  Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate).

Authors:  A S Fix; J W Horn; L L Truex; R A Smith; E Gomez
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801.

Authors:  R N Auer; K C Coulter
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Blockade by polyamine NMDA antagonists related to ifenprodil of NMDA-induced synthesis of cyclic GMP, increases in calcium and cytotoxicity in cultured neurones.

Authors:  P M Beart; A Schousboe; A Frandsen
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model.

Authors:  Masahiro Fuwa; Masaaki Kageyama; Koji Ohashi; Masaaki Sasaoka; Ryuichi Sato; Masami Tanaka; Kei Tashiro
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.